In 2008, Zytoprotec filed for an international patent for glucose based peritoneal dialysis fluid containing alanyl-glutamine dipeptide, the active cytoprotective compound in PD-protec®.

The patent specification was published early in 2012 and the patent was granted for Europe on 23 October 2012.

In addition, patent protection exists in Canada, Hong Kong and Japan, while in the U.S.A. the granting process is not yet entirely finished.

For ICO-protec, EU and PCT applications have been made. We went into the national phases in 2014.